Marksans Pharma Limited was formerly incorporated as 'Tasc Pharmaceuticals Limited' in April, 1982. Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals Limited to Marksans Pharma Limited from 10th October, 2005. The Company primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation. The Company's research and development facilities are located in Verna, Goa and R & D center in Navi Mumbai.
In 2004-05, the Company amalgamated with M/s. Marksans Pharma Limited, pursuant to High Court order dated 19th August, 2005.
The Company acquired majority stake in Nova Pharmaceuticals Australasia Private Limited in 2005; further, it acquired two companies, Bell Sons & Company (Druggists) Limited and Relonchem Limited in the UK in 2008. The Company received first ANDA approval in the USA in 2011. It acquired Time-Cap Laboratories Inc. in the US in 2015.
The Company launched the CNS-Cerebella division in FY 2017-18. It launched soft gelatin capsules, a niche category, Launched two products and received CRL for 4 ANDAs for approval with the USFDA.
The Company commissioned a new R&D center at Navi Mumbai, apart from one in Goa in 2019-20. Access Healthcare for Medical Products LLC, a Dubai-based front-marketing and promotion company was acquired in June, 2022.
In 2023-24, Company acquired the business unit of Tevapharm India Private Limited in Verna, Goa as a going concern via slu ...mp sale in April, 2023.
During the year 2026, the Company has incorporated two wholly owned subsidiaries viz., Marksans (Canada) Inc. in Canada and Marksans Pharma (Europe) Limited in Ireland. Secondly, the Company entered Germany, Canada and Ireland markets and launched Nova Pharma's branded prescription business in Australia and New Zealand.
FAQs on Marksans Pharma Ltd
1. Can I buy Marksans Pharma Ltd from PL Capital? ›
Yes, you can invest in Marksans Pharma Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Marksans Pharma Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Marksans Pharma Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Marksans Pharma Ltd pay dividends? ›
Yes, Marksans Pharma Ltd has a consistent history of rewarding its shareholders through dividend payouts. Dividend frequency and amounts vary depending on the company’s financial performance and board approvals. Investors holding Marksans Pharma Ltd shares on the record date announced by the company are eligible to receive dividends directly into their bank accounts linked with their Demat holdings.
3. What is the current share price of Marksans Pharma Ltd ? ›
As of
14-Aug-2026 , 15:59:23 the share price for Marksans Pharma Ltd. is ₹ 333 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Marksans Pharma Ltd ? ›
The 52-week high and low of Marksans Pharma Ltd share price is ₹ 155 - ₹ 336.6 as of
14-Aug-2026 , 15:59:23 .
Open Your Demat Account with PL Capital now
10 Lakh+ Active users
Award Winning research insights
No hidden charges
Start Stock SIP
Start SIP in Marksans Pharma Ltd
Invest systematically in stocks with the PL Capital app
